PHAR: Pharming Group N.V. - ADS, each representing 10
今日PHAR汇率已更改13.50%。当日,交易品种以低点16.65和高点17.76进行交易。
关注Pharming Group N.V. - ADS, each representing 10动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PHAR新闻
- Earnings Estimates Moving Higher for Pharming Group (PHAR): Time to Buy?
- Does Pharming Group (PHAR) Have the Potential to Rally 100.91% as Wall Street Analysts Expect?
- Pharming Group股价达到52周高点17.1美元
- Pharming Group stock hits 52-week high at 17.1 USD
- Morning Bid: Nerves rising about frothy valuations
- FDA批准leniolisib用于儿童APDS,Pharming Group股价上涨
- Pharming Group stock rises as FDA approves leniolisib for pediatric APDS
- Pharming shares jump 6% as FDA grants priority review for Joenja in children
- Trading Day: On the verge of a US shutdown
- CDTX Stock Soars 218% YTD on Positive Updates From Influenza Program
- QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study
- FDA Extends Review Period of Sanofi's Multiple Sclerosis Drug Filing
- Zoetis Gains CVMP Backing for Portela, Eyes EU Approval in Cat OA Pain
- RAPP Stock Soars 62% in a Week on Meeting Phase II Epilepsy Study Goal
- TVTX Stock Soars as FDA Waives Advisory Committee for Filspari sNDA
- RARE Reports Positive Long-Term Data From Metabolic Disorder Study
- Pharming Group N.V. (PHAR) Presents at H.C. Wainwright 27th Annual Global Investment Conference - Slideshow (NASDAQ:PHAR)
- IMVT Stock Up 11% on Upbeat Batoclimab Hyperthyroidism Study Results
- Editas Nominates EDIT-401 as Lead In Vivo Therapy for High Cholesterol
- Beat the Market the Zacks Way: Oracle, Intellia, Pharming Group in Focus
- OTLK Stock Crashes 54% as FDA Issues Second CRL for Eye Disease Drug
- Catalyst Pharmaceuticals Settles Firdapse Patent Litigation With Lupin
- Wall Street Analysts See a 142.26% Upside in Pharming Group (PHAR): Can the Stock Really Move This High?
- Wall Street Analysts Think Pharming Group (PHAR) Could Surge 145.75%: Read This Before Placing a Bet
常见问题解答
PHAR股票今天的价格是多少?
Pharming Group N.V. - ADS, each representing 10股票今天的定价为17.49。它在16.65 - 17.76范围内交易,昨天的收盘价为15.41,交易量达到157。PHAR的实时价格图表显示了这些更新。
Pharming Group N.V. - ADS, each representing 10股票是否支付股息?
Pharming Group N.V. - ADS, each representing 10目前的价值为17.49。股息政策取决于公司,而投资者也会关注129.53%和USD。实时查看图表以跟踪PHAR走势。
如何购买PHAR股票?
您可以以17.49的当前价格购买Pharming Group N.V. - ADS, each representing 10股票。订单通常设置在17.49或17.79附近,而157和3.92%显示市场活动。立即关注PHAR的实时图表更新。
如何投资PHAR股票?
投资Pharming Group N.V. - ADS, each representing 10需要考虑年度范围7.36 - 17.76和当前价格17.49。许多人在以17.49或17.79下订单之前,会比较31.50%和。实时查看PHAR价格图表,了解每日变化。
Pharming Group N.V.股票的最高价格是多少?
在过去一年中,Pharming Group N.V.的最高价格是17.76。在7.36 - 17.76内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪Pharming Group N.V. - ADS, each representing 10的绩效。
Pharming Group N.V.股票的最低价格是多少?
Pharming Group N.V.(PHAR)的最低价格为7.36。将其与当前的17.49和7.36 - 17.76进行比较,可以发现潜在的长期切入点。观看PHAR在图表上的实时走势以获取更多详细信息。
PHAR股票是什么时候拆分的?
Pharming Group N.V. - ADS, each representing 10历史上曾经历过股票拆分。这些变化在公司行动后的、15.41和129.53%中可见。
- 前一天收盘价
- 15.41
- 开盘价
- 16.83
- 卖价
- 17.49
- 买价
- 17.79
- 最低价
- 16.65
- 最高价
- 17.76
- 交易量
- 157
- 日变化
- 13.50%
- 月变化
- 31.50%
- 6个月变化
- 51.43%
- 年变化
- 129.53%